Skip to main content
. 2026 Apr 14;123(16):e2523148123. doi: 10.1073/pnas.2523148123

Fig. 6.

A five-panel figure shows the concentration of plasma sTrem 2 and sGpnmb in control group and stroke patients. ROC curves are also shown.

Plasma sTrem2 and sGpnmb correlate with poor stroke outcomes in patients. (A) Clinical study design: Blood was collected from patients and controls for plasma sTrem2 and sGpnmb measurement by ELISA; neurological function was assessed. (B) Plasma sTrem2 and sGpnmb levels in controls (n = 7) and stroke patients (n = 41). (C) Correlation between plasma sTrem2 and sGpnmb. (D) Levels of sTrem2 and sGpnmb in patients with good vs. poor outcomes (n = 8). (E) ROC curves show predictive value of sTrem2 and sGpnmb for stroke outcomes.